Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical management

Mariette Baud, Antonio Bobbio, Filippo Lococo, Jean François Regnard, Marco Alifano

Research output: Contribution to journalArticle

Abstract

Malignant pleural mesothelioma remains an incurable disease for which the optimal therapeutic approach remains an extremely debated issue. Though not yet clearly defined, a subset of patients may benefit from a surgery-based multimodal treatment plan, beyond what would be expected with non-surgical therapies only. Indeed, despite some disappointing results on the feasibility of a multimodality treatment (chemotherapy+surgery and post-operative radiation therapy) based on a lung sacrificing surgery (extrapleural pleuropnemonectomy) have been recently reported, the question concerning the role of extrapleural pneumonectomy in selected mesothelioma patients is still unanswered. In the light of this, we have reviewed our monoinstitutional retrospective experience in the mesothelioma management, discussing on the role of extrapleural pneumonectomy in the multimodality treatment.

Original languageEnglish
Pages (from-to)1127-1129
Number of pages3
JournalJapanese Journal of Clinical Oncology
Volume44
Issue number11
DOIs
Publication statusPublished - 2014

Fingerprint

Pneumonectomy
Mesothelioma
Combined Modality Therapy
Therapeutics
Radiotherapy
Drug Therapy
Lung

Keywords

  • Chemotherapy
  • Decortication
  • Mesothelioma
  • Pleura
  • Pneumonectomy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical management. / Baud, Mariette; Bobbio, Antonio; Lococo, Filippo; Regnard, Jean François; Alifano, Marco.

In: Japanese Journal of Clinical Oncology, Vol. 44, No. 11, 2014, p. 1127-1129.

Research output: Contribution to journalArticle

@article{5dbb8e6df8eb4fb9b0cbee3095c73516,
title = "Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical management",
abstract = "Malignant pleural mesothelioma remains an incurable disease for which the optimal therapeutic approach remains an extremely debated issue. Though not yet clearly defined, a subset of patients may benefit from a surgery-based multimodal treatment plan, beyond what would be expected with non-surgical therapies only. Indeed, despite some disappointing results on the feasibility of a multimodality treatment (chemotherapy+surgery and post-operative radiation therapy) based on a lung sacrificing surgery (extrapleural pleuropnemonectomy) have been recently reported, the question concerning the role of extrapleural pneumonectomy in selected mesothelioma patients is still unanswered. In the light of this, we have reviewed our monoinstitutional retrospective experience in the mesothelioma management, discussing on the role of extrapleural pneumonectomy in the multimodality treatment.",
keywords = "Chemotherapy, Decortication, Mesothelioma, Pleura, Pneumonectomy",
author = "Mariette Baud and Antonio Bobbio and Filippo Lococo and Regnard, {Jean Fran{\cc}ois} and Marco Alifano",
year = "2014",
doi = "10.1093/jjco/hyu134",
language = "English",
volume = "44",
pages = "1127--1129",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical management

AU - Baud, Mariette

AU - Bobbio, Antonio

AU - Lococo, Filippo

AU - Regnard, Jean François

AU - Alifano, Marco

PY - 2014

Y1 - 2014

N2 - Malignant pleural mesothelioma remains an incurable disease for which the optimal therapeutic approach remains an extremely debated issue. Though not yet clearly defined, a subset of patients may benefit from a surgery-based multimodal treatment plan, beyond what would be expected with non-surgical therapies only. Indeed, despite some disappointing results on the feasibility of a multimodality treatment (chemotherapy+surgery and post-operative radiation therapy) based on a lung sacrificing surgery (extrapleural pleuropnemonectomy) have been recently reported, the question concerning the role of extrapleural pneumonectomy in selected mesothelioma patients is still unanswered. In the light of this, we have reviewed our monoinstitutional retrospective experience in the mesothelioma management, discussing on the role of extrapleural pneumonectomy in the multimodality treatment.

AB - Malignant pleural mesothelioma remains an incurable disease for which the optimal therapeutic approach remains an extremely debated issue. Though not yet clearly defined, a subset of patients may benefit from a surgery-based multimodal treatment plan, beyond what would be expected with non-surgical therapies only. Indeed, despite some disappointing results on the feasibility of a multimodality treatment (chemotherapy+surgery and post-operative radiation therapy) based on a lung sacrificing surgery (extrapleural pleuropnemonectomy) have been recently reported, the question concerning the role of extrapleural pneumonectomy in selected mesothelioma patients is still unanswered. In the light of this, we have reviewed our monoinstitutional retrospective experience in the mesothelioma management, discussing on the role of extrapleural pneumonectomy in the multimodality treatment.

KW - Chemotherapy

KW - Decortication

KW - Mesothelioma

KW - Pleura

KW - Pneumonectomy

UR - http://www.scopus.com/inward/record.url?scp=84922392015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922392015&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyu134

DO - 10.1093/jjco/hyu134

M3 - Article

C2 - 25187665

AN - SCOPUS:84922392015

VL - 44

SP - 1127

EP - 1129

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 11

ER -